- Statement of Beneficial Ownership (SC 13D)
08 7월 2010 - 2:18AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
(Name of Issuer)
Common Stock, par value $.001
(Title of Class of Securities)
(CUSIP Number)
Jean-François Joly
Credit Industriel et Commercial
6 avenue de Provence
75009 Paris, France
+33 1 45 96 90 72
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box.
o
Note:
Schedules filed in paper format shall
include a signed original and five copies of the schedule, including all exhibits. See Rule
13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for
a reporting person’s initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would alter disclosures
provided in a prior cover page.
The information required on the remainder of this cover
page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities
Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
|
|
|
1
|
|
NAMES OF REPORTING PERSONS
Credit Industriel et Commercial
|
|
|
|
|
|
|
|
|
|
2
|
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
|
|
|
(a)
o
|
|
|
(b)
o
|
|
|
|
|
|
3
|
|
SEC USE ONLY
|
|
|
|
|
|
|
|
|
|
|
|
4
|
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
|
|
|
|
|
|
PF
|
|
|
|
|
|
5
|
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
|
|
|
|
|
|
o
|
|
|
|
|
|
6
|
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
|
|
|
France
|
|
|
|
|
|
|
|
7
|
|
SOLE VOTING POWER
|
|
|
|
|
|
NUMBER OF
|
|
1,765,174
|
|
|
|
|
|
|
SHARES
|
8
|
|
SHARED VOTING POWER
|
|
BENEFICIALLY
|
|
|
|
OWNED BY
|
|
Nil
|
|
|
|
|
|
|
EACH
|
9
|
|
SOLE DISPOSITIVE POWER
|
|
REPORTING
|
|
|
|
PERSON
|
|
1,765,174
|
|
|
|
|
|
|
WITH
|
10
|
|
SHARED DISPOSITIVE POWER
|
|
|
|
|
|
|
|
Nil
|
|
|
|
|
|
11
|
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
|
|
|
1,765,174
|
|
|
|
|
|
12
|
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
|
|
|
o
|
|
|
|
|
|
13
|
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
|
|
|
|
|
|
5.21%*
|
|
|
|
|
|
14
|
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
|
|
|
BK
|
* Based on a total number of InVentiv Health Inc. shares of common stock outstanding of 33,890,968.
Page 2 of 5
Item 1. Security and Issuer
This statement on Schedule 13D (this “Statement”) relates to common stock of InVentiv Health Inc.
(the “Issuer”). The Issuer’s principal offices are located at 500 Atrium Drive Somerset, NJ 08873.
Item 2. Identity and Background
(a) This Statement is filed by and on behalf of Credit Industriel et Commercial (“CIC”).
(b) — (c)
CIC is a French authorized bank. Our address is 6 avenue de Provence, 75009 Paris, France.
(d) — (e)
We have not, during the past five years, (i) been convicted in a criminal proceeding (excluding
traffic violations or similar misdemeanors) or (ii) been party to a civil proceeding of a judicial
or administrative body of competent jurisdiction as a result of which we are or were subject to a
judgment, decree or final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding a violation in respect to such
laws.
Item 3. Source and Amount of Funds or Other Consideration
390,398 of the shares were acquired in market purchases over the course of the 30 days prior to the
date of this filing.
In addition, 1,374,776 of the shares were acquired pursuant to a stock loan agreement, dated
October 1, 2005, by and between CIC and Cigogne (the “Stock Loan Agreement”), as amended by the Amendment Agreement dated as of April 18, 2008 (the “Amendment Agreement”). References to, and
descriptions of, the Stock Loan Agreement set forth herein are qualified in their entirety by
reference to the copy of the Stock Loan Agreement included as Exhibit 1 to this Statement, which is
incorporated by reference herein in its entirety where such references and descriptions appear.
Item 4. Purpose of Transaction
The shares were purchased for investment purposes and were not acquired with the purpose or intent
of changing or influencing the control of the Issuer.
Except as stated above, there are no plans or proposals of the type referred to in clauses (a)
through (j) of Item 4 of Schedule 13D, as promulgated by the Securities and Exchange Commission.
Item 5. Interest in Securities of the Issuer
(a) As of the date of this Schedule 13D, CIC is the beneficial owner of 1,765,174 shares of common
stock of the Issuer constituting approximately 5.21% of the total issued and outstanding shares of
common stock of the Issuer.
(b) As of the date of this Schedule 13D, CIC may be deemed to hold sole power to vote and to
dispose of the 1,765,174 shares of common stock of the Issuer as described in (a) above.
Page 3 of 5
(c) Transactions made by CIC in the common stock of the Issuer effected in the past 60 days are
below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quantity Acquired
|
|
|
Price Per Share
|
|
|
Manner of
|
|
|
Date of Transaction
|
|
(Sold)
|
|
|
(U.S. $)
|
|
|
Acquisition/Disposition
|
|
|
June 9, 2010
|
|
|
10,000
|
|
|
|
24.95
|
|
|
Purchase
|
|
|
|
|
130,538
|
|
|
|
25.00
|
|
|
Purchase
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 10, 2010
|
|
|
52,356
|
|
|
|
25.01
|
|
|
Purchase
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 11, 2010
|
|
|
10,000
|
|
|
|
25.00
|
|
|
Purchase
|
|
|
|
|
53,875
|
|
|
|
25.02
|
|
|
Purchase
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 14, 2010
|
|
|
32,550
|
|
|
|
25.04
|
|
|
Purchase
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2010
|
|
|
23,870
|
|
|
|
25.06
|
|
|
Purchase
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 16, 2010
|
|
|
57,959
|
|
|
|
25.20
|
|
|
Purchase
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 17, 2010
|
|
|
14,250
|
|
|
|
25.24
|
|
|
Purchase
|
|
|
|
|
427,530
|
|
|
|
25.19
|
|
|
Borrowed
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 1, 2010
|
|
|
5,000
|
|
|
|
25.61
|
|
|
Purchase
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
July 2, 2010
|
|
|
947,246
|
|
|
|
25.60
|
|
|
Borrowed
|
(d) No person other than CIC is known by CIC to have the right to receive, or the power to direct
the receipt of, dividends from, or proceeds from the sale of, the shares of Common Stock of the
Issuer reported in this Schedule 13D.
(e) None.
Item 6. Contracts, Arrangement, Understandings or Relationships with Respect to Securities of the
Issuer
Stock Loan Agreement by and between CIC and Cigogne dated October 1, 2005.
Item 7. Material to be Filed as Exhibits.
Exhibit 1: Stock Loan Agreement by and between CIC and Cigogne dated October 1, 2005.
Exhibit 2: Amendment Agreement by and between CIC and Cigogne dated April 28, 2008.
Page 4 of 5
SIGNATURES
After reasonable inquiry and to the best of my knowledge, I certify that the information set forth
in this statement is true, complete and correct.
Dated: July 2, 2010
|
|
|
|
|
|
CREDIT INDUSTRIEL ET COMMERCIAL
|
|
|
|
By:
|
/s/ Jean-François Joly
|
|
|
|
|
Name:
|
Jean-François Joly
|
|
|
|
|
Title:
|
Head of Legal and Tax Department
|
|
|
Page 5 of 5
Ventiv Health (NASDAQ:VTIV)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Ventiv Health (NASDAQ:VTIV)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
